Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE2.9850
- TODAY'S CHANGE (%)-0.0450 (-1.4851%)
- Bid / Lots2.9800/ 21
- Ask / Lots2.9900/ 11
- Open / Previous Close3.0400 / 3.0300
- Day Range
- 52 Week Range
- Volume416,436
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 3147 | 3.09 |
| 09:36 ET | 3079 | 3.0501 |
| 09:39 ET | 11074 | 3.0381 |
| 09:41 ET | 1140 | 3.045 |
| 09:43 ET | 4900 | 3.07 |
| 09:45 ET | 5161 | 3.06 |
| 09:50 ET | 5624 | 3.08 |
| 09:52 ET | 2100 | 3.07 |
| 09:54 ET | 650 | 3.075 |
| 09:56 ET | 100 | 3.075 |
| 09:57 ET | 100 | 3.08 |
| 09:59 ET | 650 | 3.08 |
| 10:01 ET | 1925 | 3.08 |
| 10:03 ET | 1615 | 3.09 |
| 10:06 ET | 875 | 3.1 |
| 10:08 ET | 539 | 3.1065 |
| 10:10 ET | 1300 | 3.105 |
| 10:14 ET | 1100 | 3.11 |
| 10:17 ET | 1721 | 3.12 |
| 10:19 ET | 810 | 3.1 |
| 10:26 ET | 627 | 3.085 |
| 10:30 ET | 100 | 3.09 |
| 10:32 ET | 1500 | 3.08 |
| 10:33 ET | 500 | 3.09 |
| 10:35 ET | 800 | 3.09 |
| 10:37 ET | 120 | 3.085 |
| 10:44 ET | 100 | 3.09 |
| 10:46 ET | 1815 | 3.085 |
| 10:48 ET | 300 | 3.0801 |
| 10:51 ET | 109 | 3.085 |
| 10:53 ET | 100 | 3.085 |
| 10:55 ET | 100 | 3.09 |
| 11:00 ET | 100 | 3.09 |
| 11:02 ET | 800 | 3.095 |
| 11:04 ET | 1764 | 3.108 |
| 11:06 ET | 200 | 3.115 |
| 11:08 ET | 1700 | 3.1194 |
| 11:09 ET | 100 | 3.115 |
| 11:11 ET | 5433 | 3.105 |
| 11:13 ET | 100 | 3.115 |
| 11:18 ET | 450 | 3.115 |
| 11:20 ET | 3427 | 3.105 |
| 11:22 ET | 100 | 3.105 |
| 11:24 ET | 211 | 3.105 |
| 11:26 ET | 452 | 3.105 |
| 11:27 ET | 2158 | 3.105 |
| 11:29 ET | 1236 | 3.105 |
| 11:31 ET | 11344 | 3.1 |
| 11:38 ET | 100 | 3.105 |
| 11:49 ET | 109 | 3.105 |
| 11:54 ET | 7882 | 3.105 |
| 11:56 ET | 100 | 3.105 |
| 12:00 ET | 2200 | 3.11 |
| 12:02 ET | 1100 | 3.11 |
| 12:03 ET | 9824 | 3.13 |
| 12:05 ET | 5500 | 3.13 |
| 12:14 ET | 500 | 3.13 |
| 12:16 ET | 100 | 3.14 |
| 12:20 ET | 10010 | 3.105 |
| 12:21 ET | 820 | 3.105 |
| 12:23 ET | 1019 | 3.1022 |
| 12:27 ET | 1163 | 3.105 |
| 12:32 ET | 437 | 3.105 |
| 12:34 ET | 100 | 3.105 |
| 12:36 ET | 1000 | 3.105 |
| 12:38 ET | 1470 | 3.105 |
| 12:39 ET | 420 | 3.105 |
| 12:43 ET | 150 | 3.105 |
| 12:50 ET | 700 | 3.11 |
| 12:52 ET | 100 | 3.105 |
| 12:57 ET | 460 | 3.11 |
| 01:01 ET | 100 | 3.11 |
| 01:03 ET | 344 | 3.105 |
| 01:06 ET | 300 | 3.105 |
| 01:08 ET | 13526 | 3.105 |
| 01:14 ET | 241 | 3.102 |
| 01:19 ET | 588 | 3.105 |
| 01:21 ET | 588 | 3.105 |
| 01:26 ET | 180 | 3.105 |
| 01:28 ET | 322 | 3.105 |
| 01:35 ET | 200 | 3.105 |
| 01:42 ET | 400 | 3.105 |
| 01:44 ET | 100 | 3.105 |
| 01:46 ET | 302 | 3.105 |
| 01:50 ET | 607 | 3.105 |
| 01:51 ET | 200 | 3.11 |
| 02:02 ET | 544 | 3.105 |
| 02:11 ET | 586 | 3.105 |
| 02:13 ET | 100 | 3.105 |
| 02:18 ET | 284 | 3.1001 |
| 02:20 ET | 29214 | 3.07 |
| 02:22 ET | 6431 | 3.035 |
| 02:24 ET | 5768 | 3.04 |
| 02:26 ET | 500 | 3.04 |
| 02:27 ET | 3625 | 3.055 |
| 02:29 ET | 3470 | 3.0396 |
| 02:31 ET | 200 | 3.035 |
| 02:33 ET | 200 | 3.035 |
| 02:36 ET | 1633 | 3.05 |
| 02:38 ET | 900 | 3.05 |
| 02:40 ET | 11267 | 3.035 |
| 02:42 ET | 7799 | 3.0199 |
| 02:44 ET | 1244 | 3.01 |
| 02:45 ET | 1300 | 3.0088 |
| 02:47 ET | 4211 | 2.99 |
| 02:49 ET | 5169 | 3.01 |
| 02:51 ET | 200 | 3.01 |
| 02:54 ET | 1250 | 3.01 |
| 02:56 ET | 7421 | 3.015 |
| 02:58 ET | 300 | 3.01 |
| 03:00 ET | 1630 | 3.005 |
| 03:02 ET | 500 | 3.0062 |
| 03:03 ET | 9430 | 2.985 |
| 03:05 ET | 9133 | 2.99 |
| 03:07 ET | 1650 | 2.9701 |
| 03:09 ET | 2150 | 2.975 |
| 03:12 ET | 6907 | 2.995 |
| 03:14 ET | 4440 | 2.995 |
| 03:16 ET | 600 | 2.995 |
| 03:18 ET | 700 | 3 |
| 03:20 ET | 9077 | 2.9799 |
| 03:21 ET | 6417 | 2.9792 |
| 03:23 ET | 2500 | 2.975 |
| 03:25 ET | 100 | 2.98 |
| 03:27 ET | 16692 | 2.995 |
| 03:30 ET | 3525 | 2.995 |
| 03:32 ET | 200 | 2.995 |
| 03:34 ET | 852 | 3 |
| 03:36 ET | 2552 | 3.005 |
| 03:38 ET | 400 | 3.01 |
| 03:39 ET | 3462 | 3.01 |
| 03:41 ET | 5750 | 3.005 |
| 03:43 ET | 12426 | 2.995 |
| 03:45 ET | 1000 | 3 |
| 03:48 ET | 13725 | 2.99 |
| 03:50 ET | 1000 | 2.985 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 425.0M | -11.4x | --- |
Astria Therapeutics Inc | 534.3M | -4.2x | --- |
Compass Pathways PLC | 537.2M | -3.4x | --- |
Cabaletta Bio Inc | 527.0M | -6.8x | --- |
Olema Pharmaceuticals Inc | 521.1M | -4.6x | --- |
Celcuity Inc | 512.5M | -6.2x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $425.0M |
|---|---|
Revenue (TTM) | $8.9M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.69 |
EPS | $-0.26 |
Book Value | $0.62 |
P/E Ratio | -11.4x |
Price/Sales (TTM) | 47.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
